Edition:
United Kingdom

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

90.73USD
12 Dec 2018
Change (% chg)

$0.93 (+1.04%)
Prev Close
$89.80
Open
$90.90
Day's High
$92.04
Day's Low
$90.66
Volume
391,797
Avg. Vol
614,769
52-wk High
$96.52
52-wk Low
$70.20

Latest Key Developments (Source: Significant Developments)

Zoetis Announces Authorization Of $2 Billion Share Repurchase Program
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - Zoetis Inc ::ZOETIS ANNOUNCES AUTHORIZATION OF $2 BILLION SHARE REPURCHASE PROGRAM.ZOETIS INC - DECLARED A Q1 2019 DIVIDEND OF $0.164 PER SHARE.ZOETIS INC - CO'S PREVIOUS $1.5 BILLION SHARE REPURCHASE PROGRAM, IS EXPECTED TO BE COMPLETED IN H1 OF NEXT YEAR.ZOETIS INC - BOARD DECLARED Q1 2019 DIVIDEND OF $0.164 PER SHARE, INCREASE OF 30% FROM QTRLY DIVIDEND RATE PAID IN 2018.  Full Article

Zoetis Files For Potential Mixed Shelf Offering; Size Not Disclosed
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Zoetis Inc ::ZOETIS FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.ZOETIS INC - IN ADDITION, SELLING SECURITYHOLDERS MAY OFFER CO'S SECURITIES FROM TIME TO TIME.  Full Article

Zoetis Says Upon Deal Termination By Abaxis Or Co, Termination Fee Of $70 Mln May Be Payable By Abaxis
Wednesday, 16 May 2018 

May 16 (Reuters) - Abaxis Inc ::ZOETIS SAYS UPON DEAL TERMINATION BY ABAXIS OR CO, TERMINATION FEE OF $70 MILLION MAY BE PAYABLE BY ABAXIS - SEC FILING.  Full Article

Zoetis To Acquire Abaxis for about $2 Bln In Aggregate
Wednesday, 16 May 2018 

May 16 (Reuters) - Zoetis Inc ::ZOETIS TO ACQUIRE ABAXIS, A LEADING GLOBAL PROVIDER OF VETERINARY POINT-OF-CARE DIAGNOSTIC INSTRUMENTS.ZOETIS INC - PURCHASE PRICE OF DEAL WAS $83 PER SHARE IN CASH, OR APPROXIMATELY $2.0 BILLION IN AGGREGATE.ZOETIS INC - EXPECTS TRANSACTION TO BE ACCRETIVE TO EARNINGS IN 2019.ZOETIS INC - INTENDS TO FUND PURCHASE THROUGH A COMBINATION OF EXISTING CASH AND NEW DEBT.ZOETIS - EXPECTS DEAL TO HAVE IMPACT ON 2018 EARNINGS RELATED TO CUSTOMARY CLOSING ACTIVITIES; ON ADJUSTED BASIS, CO DOES NOT EXPECT MATERIAL IMPACT.  Full Article

Zoetis Says Preliminarily Estimated Reduction To Gaap Net Income In Q4
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Zoetis Inc ::ZOETIS SAYS EVALUATING IMPACT OF U.S. TAX ACT, PRELIMINARILY ESTIMATED REDUCTION TO GAAP NET INCOME IN Q4 .  Full Article

Zoetis Board Approves 20% Dividend Increase
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Zoetis Inc ::ZOETIS DECLARES FIRST QUARTER 2018 DIVIDEND; BOARD APPROVES 20% PAYMENT INCREASE.ZOETIS - BOARD DECLARED Q1 2018 DIVIDEND PAYABLE TO HOLDERS OF CO'S COMMON STOCK OF $0.126 PER SHARE, UP 20% FROM QTRLY DIVIDEND RATE PAID IN 2017.  Full Article

Nippon Soda to buy plant health business from Zoetis Japan
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Nippon Soda Co Ltd <4041.T>:Says it will complete acquisition of plant health business from Zoetis Japan, which is engaged in manufacture and sale of veterinary drugs, feed additives and agricultural drugs, in late March, 2018.Price not disclosed .  Full Article

Zoetis Inc Q3 earnings per share $0.61
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Zoetis Inc :Zoetis announces third quarter 2017 results.Q3 adjusted earnings per share $0.65.Q3 earnings per share $0.61.Q3 revenue $1.3 billion versus i/b/e/s view $1.32 billion.Sees FY 2017 earnings per share $2.16 to $2.23.Sees FY 2017 revenue $5.225 billion to $5.275 billion.Sees FY 2017 adjusted earnings per share $2.34 to $2.39.Q3 earnings per share view $0.62 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $2.34, revenue view $5.20 billion -- Thomson Reuters I/B/E/S.  Full Article

EXCLUSIVE-Activist investor Elliott has stake in Germany's Bayer -sources

FRANKFURT/NEW YORK, Dec 7 Activist investor Elliott has taken a position in Germany's Bayer, adding to the slew of investments the fund has made in German companies, three people familiar with the matter told Reuters on Friday.